Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
N Engl J Med
    July 2024
  1. FAKIH MG, Chao J
    Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.
    N Engl J Med. 2024;391:187.
    >> Share

  2. FOJO T
    Sotorasib in KRAS-Mutated Colorectal Cancer.
    N Engl J Med. 2024;391:186-187.
    >> Share

    June 2024
  3. IMPERIALE TF, Porter K, Limburg PJ
    Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
    N Engl J Med. 2024;390:2225.
    >> Share

  4. CHUNG DC, Raymond VM, Grady WM
    Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
    N Engl J Med. 2024;390:2224-2225.
    >> Share

  5. MANNUCCI A, Goel A
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2224.
    >> Share

  6. SAFARI F, Noursina A, Rouzbahani S
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2223-2224.
    >> Share

  7. MATUCHANSKY C
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2222-2223.
    >> Share

  8. CERCEK A
    Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?
    N Engl J Med. 2024;390:2024-2025.
    >> Share

  9. CHALABI M, Verschoor YL, Tan PB, Balduzzi S, et al
    Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.
    N Engl J Med. 2024;390:1949-1958.
    >> Share

    April 2024
  10. MARIN-ESTEBAN V, Molet L, Lagana M, Ciocan D, et al
    CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
    N Engl J Med. 2024;390:1339-1341.
    >> Share

    March 2024
  11. LO YMD
    Cell-free DNA for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1047-1050.
    >> Share

  12. CARETHERS JM
    Improving Noninvasive Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1045-1046.
    >> Share

  13. IMPERIALE TF, Porter K, Zella J, Gagrat ZD, et al
    Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:984-993.
    >> Share

  14. CHUNG DC, Gray DM 2nd, Singh H, Issaka RB, et al
    A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:973-983.
    >> Share

    December 2023
  15. YAEGER R
    Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal Cancer.
    N Engl J Med. 2023;389:2197-2199.
    >> Share

    October 2023
  16. SCHRAG D
    Preoperative Treatment of Locally Advanced Rectal Cancer. Reply.
    N Engl J Med. 2023;389:1631-1632.
    >> Share

  17. SEBAG-MONTEFIORE D, Cervantes A, Rodel C
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1631.
    >> Share

  18. SHAH N
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1630-1631.
    >> Share

  19. FAKIH MG, Salvatore L, Esaki T, Modest DP, et al
    Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2023 Oct 22. doi: 10.1056/NEJMoa2308795.
    >> Share

    August 2023
  20. SACHER A, LoRusso P, Patel MR, Miller WH Jr, et al
    Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
    N Engl J Med. 2023;389:710-721.
    >> Share

    July 2023
  21. DOSSA F, Baxter NN
    Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:375-377.
    >> Share

  22. SCHRAG D, Shi Q, Weiser MR, Gollub MJ, et al
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:322-334.
    >> Share

  23. TABERNERO J, Fakih M, Prager GW
    Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
    N Engl J Med. 2023;389:190-191.
    >> Share

  24. VAN DE HAAR J, Valeri N, Voest EE
    Third-Line Therapy in Metastatic Colorectal Cancer.
    N Engl J Med. 2023;389:190.
    >> Share

    May 2023
  25. YEKU OO, Longo DL
    Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer.
    N Engl J Med. 2023;388:1711-1714.
    >> Share

  26. PRAGER GW, Taieb J, Fakih M, Ciardiello F, et al
    Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
    N Engl J Med. 2023;388:1657-1667.
    >> Share

    March 2023
  27. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    >> Share

    January 2023
  28. DOMINITZ JA, Robertson DJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:379.
    >> Share

  29. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    >> Share

  30. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    >> Share

  31. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    >> Share

  32. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    >> Share

  33. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    >> Share

  34. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    >> Share

    December 2022
  35. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    >> Share

    November 2022
  36. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    >> Share

    October 2022
  37. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    >> Share

  38. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    >> Share

    September 2022
  39. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    >> Share

  40. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    >> Share

  41. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    >> Share

    August 2022
  42. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    >> Share

  43. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    >> Share

  44. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    >> Share

  45. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    >> Share

  46. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    >> Share

  47. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    >> Share

  48. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    >> Share

    July 2022
  49. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    >> Share

  50. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    >> Share

  51. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    >> Share

    June 2022
  52. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    >> Share

  53. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    >> Share

  54. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    >> Share

  55. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    >> Share

  56. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    >> Share

  57. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    >> Share

    April 2022
  58. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    >> Share

    February 2022
  59. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    >> Share

  60. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    >> Share

    January 2022
  61. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016